Explore more publications!

Africa News Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Observer.

Press releases published on March 31, 2026

Kloudville Accelerates by Competitors in Newly Published MarketsandMarkets™ Cloud OSS/BSS Market Global Forecast to 2032
NAPAC USA joins others for Congressional Briefing on Why Nigeria Matters, held at Capitol Hill, Washington DC.
United Planet Webinar Highlights Grassroots Leadership and Social Change in South Africa Featuring Lucinda Evans
Nxera Pharma’s Partner Centessa Pharmaceuticals to be Acquired by Lilly
MASAI UJIRI JOINS TORONTO TEMPO OWNERSHIP GROUP
Lesaka Webcast and Conference Call to Review Third Quarter 2026 Results
LIXTE Biotechnology Files 2025 Annual Report on Form 10K, Provides Operational Highlights of Transformative Year
Inhibitor Therapeutics Provides Clinical, Formulation and IP Update on Itraconazole Program for Gorlin Syndrome
e4 highlights how AI is transforming contact centres to improve efficiency and customer experience
Surge Copper Provides Corporate and Operational Update
African Rainbow Minerals Limited to Acquire Shares of Surge Copper Corp.
Lumina Strategic Minerals Group Showcased as Leading Greenland Mine Operator at PDAC 2026
CRML Confirms Outstanding 2.96% TREO and HREO Refined Concentrate, Yielding ~40% Increase in Historical Metallurgical Test Work Results at Tanbreez
New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional Facilities
Ambros Therapeutics Announces Notice of Allowance for New U.S. Patent Application Covering Neridronate for Complex Regional Pain Syndrome Type 1
Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors
Adcytherix Doses First Patient in Phase 1 Trial of ADCX-020 and Strengthens Leadership to Support Next Phase of Growth
Milestone Pharmaceuticals Announces that CARDAMYST™ (etripamil) Nasal Spray is Available on Express Scripts Commercial National Formularies
Pheast Therapeutics Advances PHST001, an IgG4 Anti-CD24 Monoclonal Antibody, into Phase 1b Combination Cohorts
Cocrystal Pharma Reports 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions